Back to search

Article

Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemia

2023-01-10

Abstract excerpt

<title>Abstract</title><p>Patients with chronic lymphocytic leukemia (CLL) were at high risk early in the COVID-19 pandemic. The Omicron SARS-CoV-2 variant is considered less aggressive, but a significant fatality rate was recently reported from CLL register studies. Here we report on Omicron hybrid immunity in CLL after vaccinations against SARS-CoV-2 followed by disease. Post-infection systemic and mucosal immun...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
158f0c35-75e1-56e6-94ff-8e0d13208fb7
DOI
10.21203/rs.3.rs-2355452/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Systemic and mucosal adaptive immunity to SARS-CoV-2 during the Omicron wave in patients with chronic lymphocytic leukemiaDOI 10.21203/rs.3.rs-2355452/v1
Impaired Neutralisation of SARS-CoV-2 Delta Variant in Vaccinated Patients With B Cell Chronic Lymphocytic LeukaemiaSemantic proximity
Antibody Responses After First and Second COVID-19 Vaccination in Patients With Chronic Lymphocytic LeukaemiaSemantic proximity
Comprehensive analysis of immune responses in CLL patients after heterologous COVID-19 vaccinationSemantic proximity
COVID-19 Vaccine Failure in Chronic Lymphocytic Leukemia and Monoclonal B-Lymphocytosis; Humoral and Cellular ImmunitySemantic proximity
Impaired Humoral Immunity to SARS-CoV-2 Vaccination in Non-Hodgkin Lymphoma and CLL PatientsSemantic proximity
mRNA vaccine induces cytotoxic CD8+ T-cell cross-reactivity against SARS-CoV-2 Omicron variant and regulates COVID-19 severitySemantic proximity
Unveiling Humoral and Cellular Immune Responses to SARS-CoV-2 in Head and Neck Cancer: A Comparative Study of Vaccination and Natural Infection in RomaniaSemantic proximity
SARS-CoV-2 vaccination unmasks distinct immune dysfunctions across lymphoma subtypes and therapiesSemantic proximity
Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: The CAPTURE studySemantic proximity
Patients with CLL have similar high risk of death upon the omicron variant of COVID-19 as previously during the pandemicSemantic proximity
Cellular Mechanisms Associated with Sub-Optimal Immune Responses to SARS-CoV-2 Bivalent Booster Vaccination in Patients with Multiple MyelomaSemantic proximity
Preserved T cell reactivity to the SARS-CoV-2 Omicron variant indicates continued protection in vaccinated individualsSemantic proximity
Select a neighboring publication to make it the new centre.